4188
E. Soleimani et al. / Tetrahedron Letters 52 (2011) 4186–4188
O
O
H
O
O
H
NC
H
R
Me
CN
R1
N
O
Me
O
CN
+
RNH2
+
H
R1
H
R1
R1
H
CN
C
5
C
1
2
N
R2
N
R2
3
O
Me
O
EtOH
CN
R1
NC
NR
H
CN
O
O
O
R1
Me
CN
H
NHR
H
R1
Me
HN
O
HN
O
R1
R2
R2
N
N
R2
R2
4
6
This Reaction
Ugi Reaction
Scheme 2. The typical Ugi reaction mechanism and the proposed overall mechanism for this reaction.
Typical procedure for the preparation of 3,3-dicyano-N-
Acknowledgments
cyclohexyl-2-phenylpropanamide (4a)
We gratefully acknowledge financial support from the Iran Na-
tional Science Foundation (INSF) and Research Council of Razi
University.
A solution of benzalaldehyde (0.106 g, 1 mmol), malononitrile
(0.066 g, 1 mmol) and acetic acid (0.060 g, 1 mmol), in EtOH
(10 mL) was stirred at 70 °C. After 30 min, cyclohexyl isocyanide
(0.109 g, 1 mmol) was added and the mixture stirred for 12 h at
70 °C. After completion of the reaction, as indicated by TLC, H2O
(10 mL) was added and the resulting precipitate washed with
H2O to afford the product 4a as a yellow powder (0.27 g, yield
Supplementary data
Supplementary data associated with this article can be found, in
97%); mp 185–187 °C. IR (KBr) (m
max/cmÀ1): 3279 (NH), 3084,
2928, 2850, 2250 (CN), 1644, 1563. MS, m/z (%): 282 (M++1, 50),
200 (15), 155 (20), 129 (25), 126 (20), 83 (100), 55 (50), 41 (25).
1H NMR (200 MHz, CDCl3): dH (ppm) 1.03–1.96 (10H, m, 5CH2 of
cyclohexyl), 3.77–3.89 (1H, m, CH–NH of cyclohexyl), 4.00 (1H, d,
References and notes
1. Dömling, A.; Ugi, I. Angew. Chem., Int. Ed. 2000, 39, 3168.
2. Weber, L. Curr. Med. Chem. 2002, 9, 1241.
3. (a) Schreiber, S.-L. Science 2000, 287, 1964; (b) Terrett, N. K. Combinatorial
Chemistry; Oxford University Press: New York, 1998.
4. (a) Dömling, A. Curr. Opin. Chem. Biol. 2000, 4, 318; (b) Dömling, A. Curr. Opin.
Chem. Biol. 2002, 6, 306; (c) Ugi, I.; Werner, B.; Dömling, A. Molecules 2003, 8,
53; (d) Weber, L. Drug Discovery Today 2002, 7, 143; (e) Orru, R. V. A.; Greef, M.
Synthesis 2003, 1471; (f) Bienaymé, H.; Hulme, C.; Oddon, G.; Schmitt, P. Chem.
Eur. J. 2000, 6, 3321; (g) Dömling, A. Chem. Rev. 2006, 106, 17; (h) Zhu, J.;
Bienaymé, H. Multicomponent Reactions; Wiley-VCH: Weinheim, 2005.
5. (a) Ugi, I.; Steinbrückner, C. Chem. Ber. 1959, 71, 386; (b) Ugi, I.; Steinbrückner,
C. Chem. Ber. 1961, 94, 734.
3
3JHH = 7.6 Hz, –CH–CH(CN)2), 4.65 (1H, d, JHH = 7.6 Hz, –CH–
3
CH(CN)2), 5.39 (1H, d, JHH = 7.3 Hz, CH–NH), 7.39–7.51 (5H, m,
H–Ar). 13C NMR (75 MHz, CDCl3): dC (ppm) 24.6, 24.7, 25.3, 32.5,
32.7 (C-cyclohexyl), 26.9 (–CH–CH(CN)2), 49.4 (–CH–CH(CN)2),
53.0 (CH–NH), 111.5, 112.1 (2CN), 128.6, 129.7, 130.0, 132.5 (C–
Ar), 166.2 (C@O). Anal. Calcd for C17H19N3O: C, 72.57; H, 6.81; N,
14.94. Found: C, 72.50; H, 6.75; N, 14.83.
6. (a) Shaabani, A.; Soleimani, E.; Rezayan, A. H. Tetrahedron Lett. 2007, 48, 2185;
(b) Shaabani, A.; Soleimani, E.; Khavasi, H. R.; Hoffmann, R. D.; Rodewald, U. C.;
Poättgen, R. Tetrahedron Lett. 2006, 47, 5493; (c) Shaabani, A.; Soleimani, E.;
Maleki, A. Tetrahedron Lett. 2006, 47, 3031; (d) Shaabani, A.; Soleimani, E.;
Maleki, A.; Moghimi-Rad, J. Mol. Divers. 2009, 13, 269; (e) Shaabani, A.;
Soleimani, E.; Rezayan, A. H.; Sarvary, A.; Khavasi, H. R. Org. Lett. 2008, 10,
2581; (f) Shaabani, A.; Soleimani, E.; Khavasi, H. R. J. Comb. Chem. 2008, 10, 442;
(g) Shaabani, A.; Soleimani, E.; Moghimi-Rad, J. Tetrahedron Lett. 2008, 49,
1277; (h) Shaabani, A.; Sarvary, A.; Soleimani, E.; Rezayan, A. H.; Heidary, M.
Mol. Divers. 2008, 12, 197; (i) Shaabani, A.; Soleimani, E.; Sarvary, A.; Rezayan,
A. H. Bioorg. Med. Chem. Lett. 2008, 18, 3968.
7. (a) Jones, G. Org. React. 1967, 15, 204; (b) Tietze, L. F. Chem. Rev. 1996, 96, 115;
(c) Leelavathi, P.; Kumar, S. R. J. Mol. Catal. A Chem. 2004, 240, 99; (d) Reddy, T.
I.; Varma, R. S. Tetrahedron Lett. 1997, 38, 1721.
8. Saegusa, T.; Ito, Y.; Tomita, S.; Kinoshita, H.; Takaishi, N. Tetrahedron 1971, 27,
27.
3,3-Dicyano-N-cyclohexyl-2-(4-nitrophenyl)propanamide (4b)
Yellow powder (0.31 g, yield 95%); mp 160–162 °C. IR (KBr)
(m
max/cmÀ1): 3273 (NH), 2926, 2850, 2215 (CN), 1646, 1524,
1349. MS, m/z (%): 327 (M++1, 25), 326 (M+, 5), 245 (25), 201
(25), 150 (50), 126 (30), 83 (100), 81 (65), 43 (85). 1H NMR (200
MHz, CDCl3): dH (ppm) 1.07–2.11 (10H, m, 5CH2 of cyclohexyl),
3.81–3.87 (1H, m, CH–NH of cyclohexyl), 4.11 (1H, d, 3JHH = 8.3 Hz,
–CH–CH(CN)2), 4.67 (1H, d, 3JHH = 8.3 Hz, –CH–CH(CN)2), 5.49 (H, d,
3JHH = 6.4 Hz, CH–NH), 7.67 (2H, d, 3JHH = 8.7 Hz, H–Ar), 8.35 (2H, d,
3JHH = 8.7 Hz, H–Ar). 13C NMR (75 MHz, DMSO-d6): dC (ppm) 24.7,
24.8, 25.5, 32.2, 32.5 (C-cyclohexyl), 26.6 (–CH–CH(CN)2), 48.7 (–
CH–CH(CN)2), 50.1 (CH–NH), 113.5, 113.6 (2CN), 124.3, 130.3,
142.1, 148.1 (C–Ar), 166.2 (C@O). Anal. Calcd for C17H18N4O3: C,
62.57; H, 5.56; N, 17.17. Found: C, 63.00; H, 5.52; N, 17.21.
9. Mironov, M. A.; Ivantsova, M. N.; Mokrushin, V. S. Synlett 2006, 615.
10. Shaabani, A.; Teimouri, M. B.; Bazgir, A.; Bijanzadeh, H. R. Mol. Divers. 2003, 6,
199.